SCHEMBL21895564

SCHEMBL21895564

C=C/C=C\c1c(C)cccc1CC(C=C)CCc1c(CC)nc(OC[C@@H](C)CCCC)nc1N(CCCCC(=O)C=C)CC(C)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21895575 0.82 — —
SCHEMBL21895619 0.82 — —
SCHEMBL21895630 0.81 — —
SCHEMBL21896266 0.78 — —
SCHEMBL22087305 0.77 — —
SCHEMBL21895594 0.76 — —
SCHEMBL21895565 0.74 — —
SCHEMBL21895733 0.72 — —
SCHEMBL21912059 0.72 — —
SCHEMBL21846275 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback